Trials / Completed
CompletedNCT00701896
Smoking Cessation Using Motivational Therapy and Varenicline
Smoking Cessation and the Natural History of HIV-Associated Emphysema
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 294 (actual)
- Sponsor
- Philip Diaz · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
People that are infected with HIV appear to be especially susceptible to the adverse effects of cigarette smoking. The purpose of this study is to determine if quitting smoking by using a specialized smoking cessation treatment can prevent one from developing accelerated lung damage, particularly emphysema.
Detailed description
HIV-infected smokers are at increased risk for life-threatening diseases, such as pneumonia. To date, very little is known about the tobacco consumption characteristics of this at-risk population of smokers, but it has been well documented that they are at high risk for smoking-related co-morbidities. In addition, few effective cessation strategies have been described in HIV-infected populations. A specialized smoking cessation that combines recommendations from an existing scientifically-valid clinical guideline with Motivational Interviewing a new pharmacotherapeutic agent, may be an effective mechanism to apply to this vulnerable population of smokers. This initial, efficacy investigation has the potential to guide future treatment and research pertaining to tobacco cessation, respiratory illness and HIV.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Varenicline tartrate | 1 mMg tablet form; daily during week 1 (pre-quit week) followed by 1 mg twice daily for weeks 2-12. |
| DRUG | Nicotine Replacement Therapy | Nicotine gum and nicotine patch |
| OTHER | Biological Control | No treatment intervention only information and procedures. |
| BEHAVIORAL | Motivational Interview | 60 minute one-on-one Interview |
Timeline
- Start date
- 2008-10-03
- Primary completion
- 2013-04-20
- Completion
- 2013-06-20
- First posted
- 2008-06-19
- Last updated
- 2021-01-15
- Results posted
- 2021-01-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00701896. Inclusion in this directory is not an endorsement.